These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16572117)

  • 21. Renal perfusion assessment by renal Doppler during fluid challenge in sepsis.
    Schnell D; Camous L; Guyomarc'h S; Duranteau J; Canet E; Gery P; Dumenil AS; Zeni F; Azoulay E; Darmon M
    Crit Care Med; 2013 May; 41(5):1214-20. PubMed ID: 23591208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery.
    Sumeray M; Robertson C; Lapsley M; Bomanji J; Norman AG; Woolfson RG
    J Nephrol; 2001; 14(5):397-402. PubMed ID: 11730274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of low-dose dopamine on renal function in uninephrectomized patients: special emphasis on kidney donors before and after nephrectomy.
    ter Wee PM; Tegzess AM; Donker AJ
    Clin Nephrol; 1987 Nov; 28(5):211-6. PubMed ID: 3427830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.
    Bellomo R; Chapman M; Finfer S; Hickling K; Myburgh J
    Lancet; 2000 Dec 23-30; 356(9248):2139-43. PubMed ID: 11191541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dopamine-induced variations in intrarenal resistance. Evaluation with Doppler ultrasound].
    Derchi LE; Robaudo C; Martinoli C; Russo R; Bertolotto M; Perrone R
    Radiol Med; 1994 Dec; 88(6):818-20. PubMed ID: 7654273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine-induced changes in renal blood flow in normals and in patients with renal dysfunction.
    Drieghe B; Manoharan G; Heyndrickx GR; Madaric J; Bartunek J; Sarno G; Vanderheyden M; De Bruyne B
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):725-30. PubMed ID: 18949800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
    Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
    Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
    Samuels J; Finkel K; Gubert M; Johnson T; Shaw A
    Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous.
    Power DA; Duggan J; Brady HR
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S23-8. PubMed ID: 10386250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pulsatility index and the resistive index in renal arteries in patients with hypertension and chronic renal failure.
    Petersen LJ; Petersen JR; Ladefoged SD; Mehlsen J; Jensen HA
    Nephrol Dial Transplant; 1995 Nov; 10(11):2060-4. PubMed ID: 8643168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
    Cobas M; Paparcuri G; De La Pena M; Cudemus G; Barquist E; Varon A
    Cardiovasc Ther; 2011 Aug; 29(4):280-4. PubMed ID: 20955210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistive Index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot study.
    Schnell D; Reynaud M; Venot M; Le Maho AL; Dinic M; Baulieu M; Ducos G; Terreaux J; Zeni F; Azoulay E; Meziani F; Duranteau J; Darmon M
    Minerva Anestesiol; 2014 Dec; 80(12):1273-81. PubMed ID: 24569358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose dopamine after kidney transplantation: assessment by Doppler ultrasound.
    Spicer ST; Gruenewald S; O'Connell PJ; Chapman JR; Nankivell BJ
    Clin Transplant; 1999 Dec; 13(6):479-83. PubMed ID: 10617237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dopamine on renal function in solitary partial nephrectomy surgery.
    O'Hara JF; Hsu TH; Sprung J; Cywinski JB; Rolin HA; Novick AC
    J Urol; 2002 Jan; 167(1):24-8. PubMed ID: 11743267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-2-induced renal dysfunction in cancer patients is reversed by low-dose dopamine infusion.
    Memoli B; De Nicola L; Libetta C; Scialò A; Pacchiano G; Romano P; Palmieri G; Morabito A; Lauria R; Conte G
    Am J Kidney Dis; 1995 Jul; 26(1):27-33. PubMed ID: 7611264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is renal dose dopamine protective or therapeutic? Yes.
    Carcoana OV; Hines RL
    Crit Care Clin; 1996 Jul; 12(3):677-85. PubMed ID: 8839599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine and renal salvage in the critically ill patient.
    Duke GJ; Bersten AD
    Anaesth Intensive Care; 1992 Aug; 20(3):277-87. PubMed ID: 1524166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.